Escherichia coli Exopolysaccharides Induced by Ceftriaxone Regulated Human Gut Microbiota in vitro

文献类型: 外文期刊

第一作者: Li, Baiyuan

作者: Li, Baiyuan;Chen, Huahai;Cao, Linyan;Hu, Yunfei;Chen, Dan;Yin, Yeshi;Yin, Yeshi

作者机构:

关键词: EPS-m2; ceftriaxone; gut microbiota; 16S rRNA gene sequencing; SCFA

期刊名称:FRONTIERS IN MICROBIOLOGY ( 影响因子:5.64; 五年影响因子:6.32 )

ISSN: 1664-302X

年卷期: 2021 年 12 卷

页码:

收录情况: SCI

摘要: A stable intestinal microflora is an essential prerequisite for human health. This study investigated the interaction between Escherichia coli exopolysaccharides (named EPS-m2) and the human gut microbiota (HGM) in vitro. The EPS-m2 was produced by E. coli WM3064 when treated with ceftriaxone. The monosaccharide composition analysis revealed that EPS-m2 is composed of glucuronic acid, glucose, fucose, galactose/N-acetyl glucosamine, arabinose, xylose, and ribose with a molar ratio of approximately 77:44:29:28:2:1:1. The carbohydrates, protein, and uronic acids contents in EPS-m2 was 78.6 +/- 0.1%, 4.38 +/- 0.11%, and 3.86 +/- 0.09%, respectively. In vitro batch fermentation experiments showed that 77% of EPS-m2 could be degraded by human fecal microbiota after 72 h of fermentation. In reverse, 16S rRNA gene sequencing analysis showed that EPS-m2 increased the abundance of Alistipes, Acinetobacter, Alloprevotella, Howardella, and Oxalobacter; GC detection illustrated that EPS-m2 enhanced the production of SCFAs. These findings indicated that EPS-m2 supplementation could regulate the HGM and might facilitate modulation of human health.

分类号:

  • 相关文献
作者其他论文 更多>>